Navigation Links
Don't rely on jaundiced eye for assessing newborns
Date:3/24/2009

For hundreds of years, doctors, nurses and midwives have visually examined newborn babies for the yellowish skin tones that signify jaundice, judging that more extensive jaundice carried a greater risk of illness.

The yellowness comes from a blood byproduct, bilirubin, and a child that develops high levels of bilirubin has a potentially serious condition called hyperbilirubinemia.

Now pediatric researchers say that this longstanding practice of visual inspection is an unreliable method of predicting the baby's risk of hyperbilirubinemia. Only infants with a total absence of visible jaundice can confidently be expected to have a very low risk of hyperbilirubinemia.

"Our study tells clinicians that our ability to estimate a baby's bilirubin level, or predict the baby's risk of developing clinically significant hyperbilirubinemia, by visually observing the extent of visual jaundice, is inadequate, and not very helpful," said study leader Ron Keren, M.D., M.P.H., a pediatrician in the Center for Pediatric Clinical Effectiveness at The Children's Hospital of Philadelphia. Keren also is a faculty member of the University of Pennsylvania School of Medicine.

The study appeared March 22 in the online version of Archives of Disease in Childhood--Fetal and Neonatal Edition.

Neonatal jaundice is very common, occurring in as many as 60 percent of newborns annually, according to the American Academy of Pediatrics. It appears as a yellow skin color, a sign of excess bilirubin, a byproduct of the normal breakdown of red blood cells. In the vast majority of cases, jaundice disappears in one to two weeks as the baby's liver reduces bilirubin to normal levels, permitting the excess to be excreted.

But extremely high levels of bilirubin can cause kernicterus, a potentially life-threatening condition that can result in long-term brain damage, hearing loss and other neurological problems. Although extremely rare, kernicter
'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Growing Link Between Diabetes and Periodontal Disease Focus of National Gathering for Health Care Leaders
2. Treating your periodontal pockets may benefit your pocket book
3. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
4. Survey confirms Americans prefer root canal treatment by endodontists
5. Most With High Blood Pressure Dont Follow Recommended Diet
6. Watch Your Mouth: Michigan Association of Endodontists Offers Four Part Series on Keeping Your Teeth Healthy
7. NYU dental researchers find evidence of periodontal disease leading to gestational diabetes
8. HPV, periodontitis work in tandem to increase risk of tongue cancer
9. Ortho Organizers(R) Introduces New Premium Product Line - O2 Select(TM) Orthodontic Instruments
10. Saving teeth by using periodontal ligament regeneration
11. Researchers uncover higher prevalence of periodontal disease in rheumatoid arthritis patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Don't rely on jaundiced eye for assessing newborns
Don't rely on jaundiced eye for assessing newborns
Breaking Medicine Technology:Cambridge Scientists Archive 500,000th Crystal Structure 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Covance Inc Invites You to Join the Webcast of Its Second Quarter 2009 Financial Results Conference Call 50805 1Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease 4686 1Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease 4686 2Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease 4686 3Living Medical Textbook 28TM 29 from Projects In Knowledge 28R 29 50802 1Living Medical Textbook 28TM 29 from Projects In Knowledge 28R 29 50802 2Living Medical Textbook 28TM 29 from Projects In Knowledge 28R 29 50802 3